HOME >> MEDICINE >> NEWS
Amid food safety concerns, K-State professor believes consumers ready for irradiated meat products

proved for irradiating meat. One involves exposing the product to a beam of electrons that destroy the bacteria, while the second involves exposing the product to radioactive cobalt, which emits gamma rays that penetrate the product in the same manner an X-ray would, to kill pathogens.

While stores are currently offering consumers a choice between ground beef processed by the traditional method or irradiated ground beef, Fox envisions a point where just irradiated meats are the norm rather than the exception.

"It think we will get to the point where it's essentially all irradiated products," Fox said. "If you look at milk, it's very difficult to find unpasteurized milk in the store. I think certainly 20 years from now we will look back at the fact that we were consuming non-irradiated ground beef and being somewhat amazed that we were doing that."

Unfortunately, Fox said, the process is not free and adds approximately 6 to 10 cents per pound to the processing cost. That additional cost will ultimately be passed on to consumers. But he believes consumers will be willing to pay extra for a safer product. Ultimately, Fox said the pace at which we see the share of irradiated beef growing in the market will depend on consumer demand.

Although irradiation adds an extra layer of defense against foodborne pathogens, Fox cautions that appropriate food handling techniques should still be followed.

"It's important to realize that the product will spoil," Fox said. "It is not sterile and should be handled in exactly the same way you would a regular product."


'"/>

Contact: John A. (Sean) Fox
jafox@k-state.edu
785-532-4446
Kansas State University
31-Oct-2002


Page: 1 2

Related medicine news :

1. Major review of subway systems suggests potential for significant health and safety hazards
2. Hormone therapy controversy raises drug safety issues
3. Article highlights confusion about Homeland Security safety symbols
4. New findings on patient safety at childrens hospitals
5. Data protection rules may risk patient safety on wards
6. First-ever safety study of medical cannabis use in Canada launched
7. FDA tried to discredit whistleblower over drug safety claims
8. Study clarifies impact of age on safety of warfarin treatment for atrial fibrillation
9. Study of cancer trials finds significant safety improvement
10. Screening for virus RNA could increase safety of organ & tissue transplantation
11. Study questions safety of heart procedures at hospitals without cardiac surgery programs

Post Your Comments:
(Date:7/21/2014)... PowerObjects, a professional services firm ... add-ons for Microsoft Dynamics CRM, has joined the ... group of the most strategic Microsoft Dynamics partners ... rank them in the highest echelon of the ... the Microsoft Dynamics Inner Circle have performed to ...
(Date:7/21/2014)... have a clot in their legs and are ... medication or undergo a minimally-invasive catheter-based clot removal ... difference in death rates between the two treatments, ... catheter procedure, according to a study by Temple ... a review of more than 90,000 cases nationwide., ...
(Date:7/21/2014)... The "viral reservoir" in which HIV can lie dormant ... earlier than previously thought, new animal research indicates. ... eradicate the AIDS-causing virus, said Harvard researchers working with ... presence of the viral reservoir remains the most significant ... HIV, known as HIV-1. "We found that the ...
(Date:7/21/2014)... (PRWEB) July 21, 2014 Western ... “Great College to Work For” by the Chronicle ... and also made the Honor Roll for the ... categories: Collaborative Governance, Compensation and Benefits, Confidence in ... Respect & Appreciation. , “Western University of Health ...
(Date:7/21/2014)... A new study suggests that potential help in lowering ... refrigerator. The study found that regular intake of ... supplements, may help ease the condition. Researchers looked ... probiotics and blood pressure. The studies involved a total ... pressure. People who consumed probiotics had an average ...
Breaking Medicine News(10 mins):Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:Temple study compares deep vein thrombosis therapies 2Health News:Temple study compares deep vein thrombosis therapies 3Health News:Temple study compares deep vein thrombosis therapies 4Health News:Animal Experiments Shed Light on HIV's Ability to Hide 2Health News:Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll 2Health News:Could Probiotics Help Tame High Blood Pressure? 2
(Date:7/21/2014)... , July 21, 2014 Integrity Applications, ... of the GlucoTrack ® model DF-F noninvasive ... has entered, through its wholly-owned subsidiary, Integrity Applications ... the manufacturing arm of Acer Inc.  Pursuant to ... service (on a non-exclusive basis) the GlucoTrack Model ...
(Date:7/21/2014)... Calif. , July 21, 2014   ... a biopharmaceutical company leading the discovery and development ... the U.S. Food & Drug Administration (FDA) has ... stranded, chemically modified oligonucleotide that binds to and ... therapeutic for the treatment of Alport syndrome, a ...
(Date:7/21/2014)... -- An International Trade Commission (ITC) ruling issued Friday held ... Taiwanese device manufacturer APEX continues to infringe ResMed patents ... is the innovation leader and pioneer in designing and ... "Our research and development teams are constantly ... comfort, performance and efficacy," said David Pendarvis , ...
Breaking Medicine Technology:Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 2Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2
Cached News: